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1.       Introduction 
 According to UNAIDS, approximately 17 million women worldwide between the ages of 15 
and 49 years are HIV positive. Most (77%) live in sub-Saharan Africa. In some regions, such as 
Botswana and Swaziland, the HIV prevalence in women attending antenatal clinics is as high as 40% 
(1). Despite the many women of reproductive age who are HIV positive, few studies have investigated 
the relationship between HIV infection during pregnancy or lactation with a focus on maternal 
nutritional status and health. In most trials in HIV-positive pregnant women, the primary focus has 
been the effect on the infant rather than the HIV-positive mother. More detailed information on 
mother to child HIV transmission is reviewed elsewhere (2). In antiretroviral therapy trials to date, the 
intervention uses the woman to deliver prevention to the infant rather than being for her benefit. 
 Although the World Health Organization (WHO) recommends that HIV-positive mothers 
avoid breastfeeding “when replacement milk is acceptable, feasible, affordable, sustainable and safe” 
(3), breastfeeding is the social norm in many parts of the world for both HIV-positive and -negative 
mothers. Anecdotal reports suggest that considerable stigma is associated with not breastfeeding. 
Despite concerns about the HIV transmission risk to the infant from breastfeeding and the possible 
effect of breastfeeding on the health and nutrition of HIV-positive mothers (4), use of replacement 
milks is largely considered unacceptable, unaffordable or unsafe (5-8). Therefore, breastfeeding likely 
will remain the norm for HIV-positive mothers in most of Africa irrespective of the effect of lactation 
on the health of the HIV-positive mother. 
 This chapter briefly reviews general nutrient needs during pregnancy and lactation and the 
effect of HIV on nutritional status and it discusses reports on nutritional status of HIV-positive 
women during pregnancy and lactation. The Medline search strategy for the literature review included 
the search words HIV and lactation, HIV and mothers, HIV and women, HIV and breastfeeding, and 
HIV and nutrition. Additional searches were performed with the limits of AIDS, human and female, 
and included search words nutrition, micronutrients, lactation and nutrition, pregnancy and nutrition, 
lactation and weight or body composition, and pregnancy and weight or body composition. HIV-
related papers identified were focused primarily in women in Africa; none was focused on women in 
Asia.  
2.      Nutritional needs during pregnancy  
 Pregnancy is an anabolic condition that affects the metabolism of all nutrients in order to 
support maternal homeostasis, foetal growth and development and to prepare for lactation. In response 
to these new demands for nutrients, one or more of the following can occur: increased deposition of 
maternal stores and foetal tissue, redistribution of nutrients, and increase or decrease in nutrient 
absorption and rate of metabolism. For adequate energy support, the maternal response may be an 
increased appetite and food intake, a reduction in lipid synthesis and maternal fat storage, a reduction 
in basal metabolic rate and/or a reduction in physical activity (9). Although multiple potential 
mechanisms can adjust for nutrient metabolism, the capacity to make adjustments is limited. If 
nutrient intake falls below a threshold, foetal growth and development are compromised as is maternal 
health (9). 
 Similarly, adequate weight gain during pregnancy is important for optimal foetal growth and 
development and for maternal fat store deposits whereas inadequate weight gain is associated with 
intrauterine growth retardation and perinatal mortality. Improved maternal and infant outcomes are 
associated with the recommended weight gains, as shown in Table 1. It is generally recommended that 
women who begin pregnancy with a normal body mass index (BMI, expressed as kg/m2; 19.8–26) 
gain 11–16 kg during pregnancy. Of this weight gain, approximately 4 kg will be deposited as 
maternal fat stores (10). Excessive gestational weight gain is a concern because of the increase in 
obesity across populations worldwide. A review of literature on North American pregnant women 
from a variety of subpopulations found that a weight gain of more than 16 kg was consistently 
associated with postpartum weight retention of more than 6 kg (11). 
 The pattern of weight gain during pregnancy is variable. In a study of approximately 400 
pregnant women in Brazil, the mean gestational weight gain was 12.9 kg (95% confidence interval 
[CI] 12.2, 13.6; range –6.0 to 33.0 kg) (12); those with a greater gestational weight gain had higher 
postpartum weight retention. In a large study of multiracial American women receiving regular 
 
 
prenatal care and who were well nourished during pregnancy, the average rate of weight gain was 
slowest in the first trimester and highest in the second trimester (13), consistent with other reports 
(10). 
 During pregnancy the maternal requirements for protein, folate, niacin, zinc, iron and iodine 
in particular are 30–50% higher than before pregnancy (14). During the first half of pregnancy, extra 
nutrients are primarily required for the increase in maternal tissues, such as expansion of blood and 
extracellular fluid volume, enlargement of the uterus and mammary tissue and fat deposition. During 
the third trimester the additional nutrients are mainly used by the foetus for rapid growth and storage.  
 The diversity of an individual’s response to changes in nutrient metabolism makes nutritional 
assessment of the pregnant woman complex (15). Interpretation of micronutrient status during 
pregnancy is a challenge because nutrient levels may be influenced by hormone-induced metabolic 
changes as well as shifts in plasma volume. No pregnancy-specific nutrient laboratory reference 
values are available for comparison, thus assessment of micronutrient status during pregnancy is 
difficult (14). Although the total amount of a nutrient in the blood may be increased, its concentration 
may be decreased because of increased plasma volume. In general, concentrations of water-soluble 
vitamin are lower during pregnancy whereas concentrations of fat-soluble vitamins are unchanged or 
slightly higher (16).  
 
2.1. Effect of maternal nutrition on infant and maternal health 
 Poor weight gain during pregnancy reflects maternal malnutrition (17). The effect of poor 
nutrition on maternal and infant morbidity and mortality in HIV-negative mothers is well 
documented. Poor nutritional status before and during pregnancy has been associated with intrauterine 
growth retardation, low birth weight and premature delivery conditions (11,18,19); these events are 
also associated with maternal HIV infection (20). Iron deficiency anaemia is associated with 
inadequate maternal weight gain, toxaemia, and labor and delivery complications with increased risk 
of maternal mortality (21,22). Though little has been published on the effect of malnutrition on 
maternal health, Tomkins (23) review concluded that malnutrition contributes to the high rate of 
maternal morbidity and mortality in developing countries. For example, in Nepal where vitamin A 
deficiency is relatively common among women, supplementation of vitamin A or β-carotene reduced 
maternal mortality by 44% compared with a placebo control group (24).  
 If a woman is poorly nourished before pregnancy, an inadequate supply of nutrients, whether 
from dietary intake or maternal stores, may cause a physiological competition for nutrients between 
the mother and the foetus, placing the well being of each at risk. King (25) suggested that nutrients are 
partitioned differently between mother and foetus depending on the mother’s preconception nutrition 
status. In marginally depleted mothers, the nutrients are preferentially allocated to maternal tissues 
whereas in severely depleted mothers, foetal needs take priority. 
 
2.2. Effect of HIV on nutritional status 
 HIV-positive women in developing countries are particularly vulnerable to nutrient 
deficiencies because of likely inadequate dietary intake and potentially increased nutrient 
requirements associated with HIV and other infections and the nutritional demands of pregnancy. HIV 
infection in adults has been associated with weight loss, progressive loss of fat-free mass (FFM) and 
fat mass (FM), and wasting, all associated with increased morbidity and mortality risks (26). More 
detailed information is reviewed elsewhere (27). Grinspoon et al. (28) found that resting energy 
expenditure in 33 HIV-positive women was higher (119% ± 23%) than in 26 HIV-negative weight-
matched control women. In a study of nonpregnant women in Zaire, Thea et al. (29) found that 51 
HIV-positive asymptomatic women had significantly more subcutaneous fat as measured by skinfold 
thicknesses and more lean body mass as measured by bioimpedance than 48 women with AIDS but 
less subcutaneous fat and lean body mass than 11 HIV-negative women. Several studies in HIV-
positive women showed that at least initially, weight loss is primarily in the form of FM (30,31). Loss 
of weight or body cell mass was associated with poorer clinical outcomes in HIV-positive men (32-
35). 
 Lindan et al. (36) conducted a prospective study of predictors of mortality in 460 HIV-
positive Rwandan women of childbearing age (mean age 28 years). The 2-year mortality for all 
women was 7% (95% CI 5%, 10%); for the 40 women with AIDS at entry, mortality was 21% (95% 
CI 8%, 34%). HIV accounted for 90% of deaths during the 2 years of follow-up; independent 
 
 
predictors of mortality included a BMI less than 21 at enrolment (relative hazard 2.3; CI 1.1, 4.8) and 
low income (relative hazard 2.3; CI 1.1, 4.5).  
 A complex bidirectional relationship exists among HIV infection, nutrition and immune 
function (37). Several studies in industrialized countries found an association between low blood 
levels of vitamins (vitamin A, vitamin E, riboflavin, pyridoxine and cobalamin) and minerals (copper 
and zinc) and HIV disease progression (38-42). More detailed information on micronutrients is 
reviewed elsewhere (43). However, little is known about micronutrient intake and status and HIV 
disease progression in developing countries nor about the micronutrient profile of women infected 
with HIV. Baum et al. (44) found that deficiencies of zinc and vitamins A and E were widespread in 
HIV-positive drug-abusing women in the United States and were more severe than in a similar cohort 
of men. In HIV-negative adults, inadequate micronutrient intake is associated with altered immune 
function. Hence there is concern that similar inadequate diets may compound the susceptibility to 
infection with a further worsening of immune function in HIV-positive individuals. 
 
2.3. Effect of pregnancy on HIV 
 For most mothers in early stages of the HIV disease, pregnancy does not appear to accelerate 
disease progression (45-47). In a study of 151 pregnant women in Tanzania, the median viral load 
(copies of HIV-1 RNA) was stable at 18 weeks gestation (20.4 x 106 copies/L), delivery (20.2 x 106 
copies/L) and 7 months postpartum (19.1 x 106 copies/L ) (48). This is somewhat similar to findings 
in the United States where RNA levels were stable during pregnancy but increased modestly after 
delivery to 18 months postpartum whether or not the mother received antiretroviral therapy (49). In 
the Tanzanian study noted above, women with more advanced disease (WHO stage 2) had higher HIV 
viral loads (median 59 x 106 copies RNA/L) than those in stage 1 (median 18.3 x 106 copies/L, P= 
0.03), though there were no differences at other stages (48). In addition, the study found that median 
CD4+ T cell count increased from 18 weeks gestation (381 x 106 cells/L) to 7 months postpartum 
(444 x 106 cells/L) with the peak at delivery (516 x 106 cells/L). A decline in absolute CD4+ T cell 
count during pregnancy is consistent with the hemodilution of pregnancy, and CD4+ and CD8+ 
percentages during pregnancy appear stable overall (45). In addition, other studies suggested that 
pregnancy itself is not associated with increased infections, HIV disease progression or HIV viral load 
RNA (50-54). 
 Potential inexpensive markers for measures of HIV disease progression in HIV-positive 
pregnant or lactating women such as lymphocyte proliferation, delayed hypersensitivity skin testing 
and antibody formation have not been validated (55,56). Use of surrogate markers of HIV disease is 
further complicated by potential influence of independent factors such as pregnancy, tuberculosis 
infection and treatment, and opportunistic infections (57,58). Mid-upper-arm circumference (MUAC) 
was not correlated to HIV RNA viral load in pregnant women (48). 
 
2.4. HIV and nutrition during pregnancy: weight gain 
 Because maternal body composition is an important determinant of maternal health and 
reproductive success, determining the influence of HIV on body composition is important. There is a 
small but growing body of evidence on the effect of HIV infection on body weight and composition 
during pregnancy. 
 Ladner et al. (59) conducted a prospective study to evaluate the effect of HIV-1 on weight 
gain in Kigali, Rwanda. Enrolment included 101 HIV-positive and 106 HIV-negative women between 
24 and 28 weeks gestation. At enrolment the mean BMI was not different for HIV-positive (24.1, SD 
2.8) and HIV-negative women (24.5, SD 4.1; P= 0.89). At the end of pregnancy the mean weight was 
not statistically different between groups (HIV-positive women: 60.7 kg, SD 6.7; HIV-negative 
women: 63.0 kg, SD 10.2; P= 0.08). Overall the HIV-positive women gained less weight than the 
HIV-negative women during pregnancy, but the slopes reflecting the rates of weight gain between 
groups were not significantly different (P= 0.058). Few women were underweight in either group 
(BMI <20: 4% in HIV-positive women, 6% in HIV-negative women; P= 0.40) but the authors noted 
that weight and BMI gains during pregnancy in both HIV-positive and -negative women were low and 
less than recommended.  
 Villamor et al. (60) obtained monthly anthropometric measurements for 957 HIV-positive 
pregnant women in Tanzania. At baseline between 12 and 27 weeks gestation, 24% were 
asymptomatic and 12% had CD4+ cell counts less than 200 x 106 cells/L. Anaemia (hemoglobin <110 
 
 
g/L) was found in 82% and malaria parasites were found in 19% of participants. The rate of weight 
gain decreased progressively during pregnancy as did MUAC. A lower baseline CD4+ T cell count 
(<200 x 106 cells/L) was associated with a poorer rate of weight gain. In the second trimester, 
advanced HIV disease, low serum selenium and malarial disease contributed to decreased rates of 
weight gain; in the third trimester those with lower education level and helminthic infections at 
baseline had a decreased rate of weight gain. The rate of weight gain in these mothers was about 55–
65% of that reported in pregnant women of undetermined HIV status in developed countries but 
similar to rates reported in developing countries. 
 The relationship between anthropometry and HIV status was examined in a cross-sectional 
study in Tanzanian women before week 23 of gestation (61). The mean BMI was no different between 
1810 HIV-positive women (23.6, SD 3.4) and 11 950 HIV-negative women (23.5, SD 3.4) nor was 
the mean MUAC (HIV-positive women: 25.4 cm, SD 2.7; HIV-negative women: 25.5 cm, SD 2.7). 
Wasting, determined as MUAC less than 22 cm, was 34% (95% CI 3%, 73%) more prevalent among 
HIV-positive mothers after adjustment for height, age, weeks of gestation and socioeconomic status. 
The risk of wasting was highest in those with fewer than 4 years of education or unable to contribute 
to household income. 
 Friis et al. (62) conducted a cross-sectional study of body composition in HIV-positive and 
-negative pregnant women between 22 and 35 weeks gestation in Harare, Zimbabwe. Mean age was 
24.4 years and 0.4% had malarial parasitaemia. No differences in anthropometric variables were 
found between the 526 HIV-positive and 1113 HIV-negative women (weight 65.2 versus 65.1 kg, 
triceps skinfold 15.9 versus 16.3 mm, respectively; BMI 25 in each group). However, women with 
HIV viral loads greater than 5 log10 had a mean weight lower by 2.5 kg (CI –0.1, 5.1; P= 0.058) and a 
mean MUAC lower by 1.10 cm (CI 0.23, 1.97; P= 0.01) than values for HIV-negative women. 
 
2.5. HIV and nutrition during pregnancy: micronutrients 
 The Women and Infants Transmission Study in North America is a large multicenter 
prospective cohort study that examined nutrition and clinical correlates during pregnancy in HIV-
positive women (63). The 256 HIV-positive women received zidovudine during pregnancy either to 
prevent mother-to-child transmission or for their own treatment. The study showed that the proportion 
of women with low serum albumin (<35 g/L) was greater in the third trimester than before the third 
trimester (45.6% vs 16.9%) and there was a significant decline with time (mean –2.3 g/L per week, 
P= 0.0001). Before the third trimester, lower CD4+ cell levels were associated with anaemia (P= 
0.01) and higher viral loads were associated with anaemia and low BMI (<25; P= 0.03 for both). In 
the third trimester both lower CD4+ cell and higher viral loads were associated with decreased serum 
albumin. The mean change in BMI throughout pregnancy was 0.114 per week. 
 In their cross-sectional study mentioned previously, Friis et al. (64) examined folate, ferritin 
and hemoglobin concentrations of 1669 pregnant Zimbabwean women between 22 and 35 weeks 
gestation. The mean serum folate concentration of 1113 HIV-negative women was 11.6 nmol/L (95% 
CI 11.4, 11.9), with 75% having deficient (<6.7 nmol/L) or marginal (6.7–13.5 nmol/L) values. The 
526 HIV-positive women had a lower mean serum folate concentration (11.0 nmol/L; 95% CI 10.6, 
11.4; P= 0.009) with a larger proportion with deficient values (16% of HIV-positive women, 10% of 
HIV-negative women; P= 0.001). Similarly, the mean hemoglobin concentration was lower in HIV-
positive (109 g/L; 95% CI 108, 110) than in HIV-negative women (118 g/L; 95% CI 117, 119; P< 
0.00001), with significantly more HIV-positive women with hemoglobin lower than 110 g/L (54% 
HIV-positive versus 22% HIV-negative women; P< 0.001). The mean serum ferritin was no different 
between groups (116 µg/L, 95% CI 112,121 in the HIV-positive group; 114 µg/L, 95% CI 107, 120 in 
the HIV-negative group, P=0.57) as was the proportion of mothers with severely depleted ferritin 
stores defined as ≤12 µg/L (63%, 95% CI 60, 66 HIV-positive mothers; 64%, 95% CI 59, 68 HIV- 
negative mothers, P=0.82). In multivariate analysis, when controlling for acute phase response as 
measured by α1-antichymotrypsin, HIV was slightly but significantly inversely related to serum 
ferritin. Friis et al. (65) also investigated vitamin A status in these women. When the acute phase 
response, as measured by α1-antichymotrypsin, was controlled for, HIV infection was associated with 
lower serum β-carotene and retinol. 
 Semba et al. (66) investigated correlations between iron status and markers of HIV disease 
progression in a cross-sectional study with 483 pregnant women in Malawi. They found a significant 
 
 
correlation between increased viral load and decreased hemoglobin level (r=  -0.104, P< 0.03). High 
plasma ferritin concentration was not related to more severe disease (viral load r= 0.044, P= 0.34; 
CD4+ count r= 0.002, P= 0.95) contrary to findings in some other studies (67-69). The prevalence of 
iron deficiency anaemia, however, was not different according to viral load or CD4+ cell count, and 
Semba et al. concluded that iron status is not related to markers of HIV disease severity as measured 
by viral load and CD4+ cell count. 
 Anaemia was also investigated using baseline data from 1064 HIV-positive pregnant women 
enrolled in the Tanzanian supplementation study (70). Eighty-three percent of the women were 
anaemic (hemoglobin <110 g/L), with mean CD4+ cell count and serum retinol levels independently 
associated and significantly positively correlated with hemoglobin. Women with BMI less than 19 
were at least three times more likely to have severe anaemia than were those with BMI greater than 
24. Folate deficiency, assessed by the presence of macrocytic cells, was found in only 5% of the 
women. 
 In a randomized trial of high-dose vitamin supplementation (vitamin A and β-carotene alone; 
multivitamins containing thiamin, riboflavin, vitamins B6 and B12, niacin, folic acid and vitamins C 
and E, with or without vitamin A; or placebo) in 1075 pregnant HIV-positive women in Tanzania, 
Fawzi et al. (71) found that CD4+ cell count increased between 18 weeks gestation and 6 weeks 
postpartum, consistent with other studies (45,53). CD4+ cell count and percentage, however, 
increased more in the women receiving supplementation than in those without supplementation. In 
addition, the women taking the multivitamins improved their iron status, with hemoglobin increasing 
by a mean of 13 g/L (SD 21) by 6 weeks postpartum compared with a mean of 6 g/L (SD 22) in those 
who had not taken supplements. Vitamin A supplementation alone did not affect CD4+ T cell count 
nor hemoglobin status.  
 In the same cohort, Villamor et al. (72) reported that women gained an average of 4.0 ± 3.2 
kg between study enrolment and the last visit before delivery, with a mean gain of 306 g/week during 
the second trimester and 247 g/week in the third trimester. During the third trimester there was a small 
but significant increased mean weight gain (304 g; 95% CI 17,590; P= 0.04) in women who received 
multivitamin supplement compared with those who did not, with a lower risk of low total weight gain 
(relative risk [RR] 0.70; 95% CI 0.55, 0.90; P= 0.005) or weight loss (RR 0.69; 95% CI 0.50, 0.95; 
P= 0.02). Vitamin A supplementation alone did not significantly affect overall weight gain. The 
authors of both reports suggest that the positive effect of multiple vitamins on maternal immunity may 
decrease the risk of secondary maternal infections during pregnancy and result in improved weight 
gain. Lower levels of anaemia in the multivitamin group may contribute to decreased maternal birth 
complications. In addition, T cell improvement could result from provision of folic acid and vitamin 
B12, which have roles in development and proliferation of cells. 
 In a study of 357 HIV-positive Kenyan women of reproductive age, high dose multiple 
vitamins with selenium versus placebo were used to determine the effect of micronutrient 
supplementation on cervical and vaginal shedding of HIV-infected cells. After 6 weeks of 
supplementation, vaginal HIV shedding was significantly higher in those supplemented than in those 
receiving placebo, suggesting that high dose multiple vitamins with selenium may increase HIV 
infectivity in women.  Supplementation resulted in higher CD4+ and CD8 lymphocyte counts, 
however, with no difference in plasma HIV viral load.  These results raise questions about the risks 
versus benefits of high dose multiple vitamin with selenium supplementation to women during 
pregnancy (73). 
 
3.      Nutritional needs during lactation  
 Requirements for many nutrients such as energy, vitamins A, C, B12 and E, riboflavin, and 
minerals iodine, selenium and zinc are considerably higher during lactation than during pregnancy 
(74,75) and are proportional to the intensity and duration of breastfeeding. Ideally, some of the 
nutrients stored during pregnancy, including energy stored as fat, will be available during lactation. 
To support the mother and infant during the first 6 months of lactation, breastfeeding mothers need to 
consume approximately 500 kcal/day in addition to usual energy intake before pregnancy. This 
assumes that approximately 170 kcal/day will be used from stores accumulated during pregnancy 
(76).  If the mother has not gained adequate weight during pregnancy, additional energy will need to 
be consumed during lactation to make up for the lack of additional stores. As with pregnancy, several 
 
 
metabolic adaptations meet the metabolic needs of lactation. These include increased appetite and 
food intake, mobilization of tissue stores and reduced physical activity. 
 Little is known about the effect of lactation on maternal micronutrient status. The mammary 
gland exerts metabolic priority for many vitamins, even at the expense of maternal stores (77). During 
lactation the maternal requirements for protein, vitamins A,  B6, and  C, riboflavin, pantothenic acid, 
zinc and iodine are 40–90% higher than before pregnancy depending on the nutrient whereas the 
requirements for thiamin, niacin, folate, vitamin E and selenium are about 25% higher (14). There is a 
decrease in the maternal requirement for iron and no change in the need for calcium, magnesium and 
phosphorus. Dewey (78) suggests that because lactation exerts the highest increase in requirement for 
vitamins A, B6 and C and for minerals iodine and zinc that the micronutrient status of these nutrients 
would most likely differ between lactating and nonlactating mothers. The effect of low maternal 
intake of various nutrients on the success of lactation or maternal and infant health remains largely 
unknown except when a nutritional deficiency is so severe that it is evident in the infant, as has been 
seen with vitamin B12 and vitamin D deficiencies. 
 Several maternal micronutrient deficiencies are likely to affect breast-milk composition, as 
summarized in the review by Allen (79). In general, inadequate maternal intake of water-soluble 
vitamins affects breast-milk concentration whereas the breast-milk is affected to a lesser extent by 
maternal intake of fat-soluble vitamins or minerals. Allen has classified micronutrients during 
lactation into 2 groups. Group 1 includes nutrients in which breast-milk concentrations are affected by 
maternal nutrient status, and include: thiamine; riboflavin; vitamins A, B6 and B12; iodine; and 
selenium. Group 2 includes nutrients not affected by maternal nutrient status: folic acid, vitamin D, 
calcium, iron, copper and zinc. In endemically deficient populations, an adequate intake of group 1 
nutrients are top priorities because maternal deficiencies of these results in lower concentration in 
breast milk and documented adverse effects in infants. The concentrations of these nutrients in breast 
milk can be improved with maternal intake, and breast milk is the primary source of most of these 
nutrients for infants.  
 
3.1. Weight change postpartum 
 Butte and Hopkinson (80) summarized results of many longitudinal studies of weight changes 
postpartum in women worldwide. They concluded that most women have a mild, gradual weight loss 
during the first 6 months postpartum but that the changes in weight are highly variable within and 
across populations. Women in more affluent countries tend to lose more weight (–0.8 kg/month) than 
those in developing countries (–0.1 kg/month). Several studies reported that women from the Gambia, 
Egypt and Taiwan gained weight postpartum. Differences were likely attributable to gestational 
weight gain, prepregnancy weight, cultural practice, physical activity and seasonal food availability, 
with gestational weight gain being the strongest and most consistent predictor. Few studies on 
changes in body composition during lactation have been conducted in developed countries. Butte and 
Hopkinson (80) used skinfold thickness measurements to measure adiposity changes during lactation 
in 45 well-nourished presumed HIV-negative women in the first 4 months of breastfeeding. They 
reported that fat was mobilized from the trunk and thighs and was redistributed to the upper body. 
Suprailiac and subscapular skinfold thicknesses decreased significantly whereas the triceps and biceps 
skinfold thicknesses did not. In addition, percent body fat determined by anthropometry decreased 
from 28% to 26–27%. 
 Brewer et al. (81) measured anthropometric changes postpartum in 56 presumed HIV-
negative American mothers during the first 6 months of lactation. Mothers who exclusively breastfed 
lost a mean of 8.3 kg (SD 0.74) whereas those who exclusively formula fed lost a mean of 7.2 kg (SD 
0.74, P< 0.01), with the largest loss of weight between 3 and 6 months in the exclusively 
breastfeeding mothers. Consistent with Butte and Hopkinson (80), suprailiac and subscapular skinfold 
thickness measurements decreased and the triceps skinfold thickness increased at 3 months, 
suggesting mobilization of fat stored during pregnancy. 
 Dugdale and Eaton-Evans (82) measured weight and skinfold thickness changes in 174 
Australian, presumed HIV-negative, breastfeeding mothers for 12 months postpartum. Mothers lost 
weight between months 1 and 6 of breastfeeding and had stable weight thereafter; women with higher 
BMI initially lost more weight than those with a lower BMI. Similar to the findings of Brewer et al. 
 
 
(81), triceps skinfold thickness increased until 5 months postpartum, when it began to decline. 
Breastfeeding duration did not affect changes in weight or skinfold thickness measurements.  
 Motil et al. (83) measured 10 exclusively breastfeeding, well-nourished, presumed HIV-
negative women at 4 times between 6 and 24 weeks postpartum. Whole-body potassium counting was 
used to determine body composition. Women maintained a mean lean body mass of 46 kg (SD 3.7–
4.8 depending on time point). Mean weight loss (0.27 kg/month) was in the form of body fat (1.4 kg, 
SD 1.8) during follow-up. 
 A meta-analysis using 41 databases and 1726 measurements was conducted to determine 
whether low BMI is a useful predictor of impaired lactational performance (84). No relationship was 
found between BMI and the volume of milk produced by mothers, even for BMIs lower than 18.5, 
and the authors concluded that BMI was not a sensitive predictor of functional lactation capacity. The 
BMIs from the studies included in this meta-analysis were between a low of 16.8 in Myanmar and a 
high of 24.4 in Zaire. 
 
3.2. Effect of lactation on HIV 
 Zimmer and Garza (85) commented in an editorial that we have limited understanding of the 
effect of lactation on the immune system of healthy women and none on that of HIV-positive women. 
No evidence supports the hypothesis of Mbori-Ngacha et al. (86) in Kenya, who suggested the 
possibility that breast milk from HIV-positive mothers may lack immunoprotective factors. Labbok 
(87) reviewed the maternal benefits of breastfeeding and concluded that little is known about the 
effects of breastfeeding on maternal health (both short and long term) because most research focused 
narrowly on human milk as a nutrient source for infants. Recently, however, several studies found that 
lactation is associated with a reduced risk of breast cancer (88–90). 
 As part of a randomized trial of abrupt breastfeeding cessation at 4 months compared with 
mothers’ choice of longer breastfeeding in Lusaka, Zambia, Kuhn et al. (unpublished, 2004) 
investigated whether prolonged breastfeeding was associated with rapid disease progression. They 
followed 695 mothers for 2 years postpartum. The study found that CD4+ counts at 12 months were 
lower in the mothers who weaned abruptly at 4 months (median CD4+ 336) compared with those 
breastfeeding for longer (median CD4+ 427, P= 0.02). The authors suggested that prolonged 
breastfeeding may provide immunological benefits to the mother. 
 In the previously mentioned Tanzanian micronutrient supplementation trial, breastfeeding 
status and duration were not associated with HIV disease progression (death, CD4+ <200 x 106 
cells/L, anemia defined as hemoglobin <85 g/L or excessive weight loss defined as >10% loss of body 
weight) (91).  In the 600 HIV-positive women with known breastfeeding duration, the mean duration 
of breastfeeding was 18 months and the mean duration of exclusive breastfeeding was 2.9 months.  
 
3.3. HIV and nutrition during lactation 
 Little is known about the effect of breastfeeding on the health and nutrition of HIV-positive 
women; reports on the nutritional status and changes over time are even fewer than those on HIV-
positive pregnant women.  
3.3.1.  Weight change postpartum  
 In their Rwandan study of HIV-positive and -negative women, Ladner et al. (59) reported 
weight changes through 5 months postpartum. Between 10 days and 5 months postpartum, both HIV-
positive and -negative mothers gained weight, but the HIV-negative mothers gained more (HIV-
positive mothers: 0.7 kg, SD 3.8; HIV-negative mothers:1.9 kg, SD 4.7; P= 0.03). BMI increased in 
both groups (HIV-positive mothers: 0.3, SD 1.5; HIV-negative mothers: 0.80, SD 1.9; P= 0.03). 
Ladner et al. do not report whether women were breastfeeding, exclusively or otherwise. In a smaller 
sample at 9 months postpartum, weight change was not different between the two groups (HIV-
positive mothers: 1.1 kg, SD 4.6; HIV-negative mothers: 1.8 kg, SD 4.8; P= 0.28). Though reports on 
lactating women of unreported HIV-status worldwide indicate that most lose some weight postpartum 
and with breastfeeding, the authors suggest that HIV infection impairs weight gain postpartum. 
 In a randomized clinical trial of formula feeding versus breastfeeding in Kenyan HIV-positive 
mothers, weight measured between 0.5 and 3 months postpartum was compared with weight 
measured between 5 and 9 months postpartum (4). Formula-feeding mothers lost no weight whereas 
breastfeeding mothers lost 0.17 kg/month (P= 0.03). The wide time span for each measurement makes 
interpretation of this finding difficult. A limitation of both these studies is that the first weight 
 
 
measurement, if taken before 6 weeks postpartum, may still include the increased fluid from 
pregnancy and thus may not represent a true baseline weight. 
 In a cross-sectional body composition study in 44 HIV-negative and 17 HIV-positive South 
African women measured at a mean of 10 weeks postpartum, no difference was detected between 
HIV-positive and -negative women in height (159.8, SD 4.5, versus 158.2, SD 5.3 cm, respectively; 
P=0.73), weight (66.7 kg, SD 9.2, versus 62.9 kg, SD 11.9, respectively; P= 0.23), BMI (26.2, SD 3.7, 
versus 25.1, SD 4.6, respectively; P= 0.40), MUAC (29.6 cm, SD 3.5, versus 28.4 cm, SD 3.9, 
respectively; P= 0.30), triceps skinfold thickness (19.0 mm, SD 7.9 mm, versus 18.8 mm, SD 7.6, 
respectively; P= 0.92) (92).  In the HIV-positive women, median CD4+ count was 631 x 106 cells/L 
and viral load was 25 x 106 RNA copies/L  (log10 4.4).  Fat free mass (FFM) as determined by 
multifrequency bioimpedance spectrometry was higher in the HIV-positive mothers (HIV-positive 
mothers: 41.7 kg, SD 4.2; HIV-negative mothers: 38.8 kg, SD 5.2; P= 0.05) and was consistent that of 
well-nourished HIV-positive nonpregnant white and black American women (93,94) and HIV-
negative breastfeeding North American women (83,95). The fat mass (FM) (HIV-positive women: 
25.9 kg, SD 7.6; HIV-negative women: 24.4 kg, SD 8.7; P= 0.53) and percent body fat appeared the 
same or higher than in reports in presumed HIV-negative breastfeeding mothers in the United States. 
 In a longitudinal study of 73 HIV-positive and 47 HIV-negative South African breastfeeding 
women, the HIV-positive mothers lost more weight between 8 and 24 weeks postpartum than did the 
HIV-negative mothers (–1.41 kg, SD 3.1, versus +0.27 kg, SD 3.33; P= 0.006, respectively), or 
approximately 0.35 kg/month loss in HIV-positive and 0.08 kg/month gain in HIV-negative mothers 
(Papathakis et al., unpublished, 2004). As measured by bioimpedance spectrometry, 92% of the 
weight loss was fat loss. At both 8 and 24 weeks postpartum the two groups did not differ in any 
anthropometric and body composition measurement (height, weight, BMI, skinfold thicknesses, 
MUAC, FFM, FM and percent body fat). At 8 weeks none of the women was considered mildly 
underweight (BMI <18.5). Conversely, one third of women in each group were classified as mildly to 
moderately overweight (BMI 25–33.9) at 8 and 24 weeks postpartum.  
 
3.3.2. Micronutrient supplementation 
 The previously mentioned Tanzanian vitamin supplementation trial examined the effect of the 
supplement on the risk of clinical HIV disease progression (96). Compared with placebo, high-dose 
vitamin B complex with vitamins C and E significantly delayed progression of HIV disease (RR of 
WHO stage 4 or death from AIDS-related causes 0.71; 95% CI, 0.51,0.98, P= 0.04) whereas vitamin 
A alone was not significantly different from the placebo. Multivitamin supplementation also 
decreased the incidence of other illnesses, such as oral thrush and ulcers, and vomiting and diarrhoea. 
The effect of the supplement was strongest in the first 2 of the 4 years of follow-up. 
 
3.3.3. Mortality  
 Several studies reported the mortality risk for HIV-positive women who breastfeed. In the 
Kenyan formula feeding trial above, maternal mortality in the 2 years after delivery was 11% among 
those who breastfed compared with 4% in those who did not (RR 3.2, 95% CI 1.3, 8.1; P= 0.01) (4). 
An RR of 3.4 (CI 2.0, 5.8) was found for weight loss of each 1 kg/month, with a median weight loss 
of 0.7 kg/month in those who died compared with a weight loss of 0.05 kg/month in those who lived. 
The authors suggested that the nutritional demands of breastfeeding together with the HIV infection 
may impair nutritional status and result in increased death. Note that although women were randomly 
assigned to the method of infant feeding, the median HIV viral load was higher in the breastfeeding 
mothers than in the formula-feeding mothers, as was the rate of intrauterine HIV transmission. These 
factors suggest that there may have been more advanced disease in the breastfeeding mothers than in 
the formula-feeding mothers (97). 
 In a randomized clinical trial of maternal vitamin A supplementation in South Africa in which 
HIV-positive women chose to breastfeed or replacement-milk-feed their infants, the mortality rate 
was not different between groups (98). In addition, the mortality rate was much lower than in the 
Kenyan study—0.5% in women who ever breastfed compared with 1.9% who never breastfed.  
 In the randomized clinical trial conducted in Zambia, Kuhn et al. (unpublished data, 2004) 
tested whether mortality among HIV-positive women was associated with prolonged breastfeeding. 
No difference was found in the Kaplan-Meier estimates of mortality between 347 HIV-positive 
 
 
women who abruptly ceased breastfeeding at 4 months (mortality at 12 months 4.6% [95% CI 
1.79,7.31]) compared with 348 HIV-positive women who were encouraged to exclusively breastfeed 
to 6 months with weaning foods introduced thereafter (4.9% [95% CI 1.91,,7.86]), P=0.954. 
 The Breastfeeding and HIV International Transmission Study analyzed individual patient data 
from clinical trials to estimate mortality risk during 18 months postpartum by breastfeeding status. 
Mortality was 28.7/1000 person years follow-up at 12 months and 32.3/1000 person years at 18 
months. Breastfeeding was not associated with mortality (P> 0.11). Independent mortality risk factors 
included low maternal CD4+ count and breastfeeding status (ever breastfed had lower risk of 
mortality at 12 months than never breastfed, P= 0.03 (99). 
 The World Health Organization concluded that there was no scientific evidence to indicate 
that breastfeeding increases mortality among HIV-positive women. It stated that further study and 
analysis are warranted before the current recommendations on feeding infants of HIV-positive 
mothers can be changed (100). 
 
4. Nutrition assessment 
 
4.1. Pregnancy 
 Body weight measured several times throughout pregnancy is most commonly used to assess 
nutritional status, and gestational weight change is routinely monitored worldwide (17). BMI, which 
takes maternal height into account, may be useful, especially in identifying those at risk, by indicating 
wasting of both fat and lean tissue. MUAC reflects past and current nutritional status but is not as 
sensitive to short-term changes in nutritional status during pregnancy (17). Skinfold thicknesses 
measured at several body sites have been shown to detect changes in subcutaneous fat distribution. In 
a study of presumed HIV-negative, mainly white American pregnant women at 30 weeks gestation, 
Huston Presley et al. (101) found that maternal weight and triceps, subscapular and suprailiac skinfold 
measurements explained 91% of the variance in FM compared with that estimated from density 
determined by underwater weighing and total body water determined by isotope dilution methods. 
They argued that because of increased plasma volume and amniotic fluid during pregnancy, weight 
alone may not be a good indicator of nutritional status. They also noted that in late gestation, most 
body composition estimation models cannot differentiate between maternal and fetal tissues. 
 Because total body water increases during pregnancy, measuring FFM accurately presents a 
challenge, especially in developing countries. Expensive and complex research methods, such as 
isotope dilution and dual-energy X-ray absorptiometry, are available but are not readily available to 
many investigators and are not practical for the field setting. Generally, height, weight, BMI, MUAC 
and skinfold thickness measurements are used to measure adiposity during pregnancy. 
 When determining the best measurement to obtain during pregnancy, it is important to 
consider the purpose of the indicator. For example, if the goal is to screen and identify women at risk, 
then BMI or MUAC can identify women who are malnourished and in need of intervention (17). 
If the goal is to measure responsiveness to an intervention, then repeated weight measurements and 
change in weight between measurements may be used (17). Change in weight between times can also 
be used to screen for those at risk. Obviously, selection of the best measurement will also depend on 
practical considerations such as equipment, facilities, training and human resources. For HIV-positive 
pregnant women, cutoff points have not yet been developed for any anthropometric indexes in relation 
to improved maternal and infant outcomes. 
 
4.2. Lactation 
 When women face food shortages during lactation, they mobilize fat or lose body weight to 
support milk production at the expense of nutritional status (81,101,102). Whether HIV poses a 
similar burden in marginally nourished women is not known.  
 In his review of weight and fat store changes during lactation, Dorea (103) suggested that 
changes in maternal body weight and FM postpartum vary considerably depending on the mother’s 
nutritional status, reproductive history and stage of lactation. Most of the maternal physiological and 
body composition changes occur during the first 3 months postpartum, with weight loss being the 
norm internationally regardless of socioeconomic status. Changes in fat are highly variable. In 
developing countries, mothers lose subcutaneous fat from all sites, and triceps skinfold thickness 
appears to be a sensitive measure in marginally nourished mothers. Affluent mothers, however, show 
 
 
more variable results: triceps skinfold measurements generally increase but the sum of skinfold 
thicknesses measured at several sites either increases or decreases. Therefore, it is recommended that 
the triceps skinfold measurement be used as an indication of fat mobilization but not necessarily of 
total body fat. Similarly, Butte and Hopkinson (80) suggested that triceps skinfold thickness 
measurements may reflect fat stores or redistribution during the first 4 months of lactation and should 
not be used alone to reliably predict total body fat. They found that the biceps and triceps skinfold 
measurements did not change significantly but that the suprailiac and subscapular skinfold 
measurements did.  
 In the previously mentioned body composition study in South Africa, all skinfold thickness 
measurements (triceps, biceps, subscapular and suprailiac), BMI and MUAC were strongly correlated 
with FM in HIV-positive and -negative breastfeeding mothers and were useful in measuring changes 
in FM (92).  For HIV-positive breastfeeding mothers, however, none of the anthropometric 
measurements was correlated with FFM, suggesting that other measurements such as bioimpedance 
should be used to accurately assess FFM. This finding is similar to that of Grinspoon et al. (28), who 
found that BMI was not correlated with FFM in non-breastfeeding HIV-positive women.  
 Reference data for assessing nutritional status and identifying individuals at risk during 
lactation are not available, but it has been suggested that a cutoff value for BMI of 20.3 at 1 month 
postpartum should be used rather than the usual 18.5; by 6 months postpartum, however, the cutoff of 
18.5 can be used to identify women at risk (17). This compares with a study conducted in the Gambia, 
where BMI<18 in HIV-positive men and women was a predictor of mortality (104). As with HIV-
positive pregnant women, when determining the best measurement to assess nutritional status during 
lactation, it is important to consider the purpose of the indicator. BMI, MUAC or change in weight 
can be used to identify women who are malnourished and in need of intervention (17). Cutoff values 
for anthropometric indexes related to improved maternal outcome or delay of disease progression  
during lactation in HIV-positive women have not yet been developed.  
 
5.      Programmatic considerations and obstacles 
 The scientific data regarding HIV-positive women who become pregnant and choose to 
breastfeed their infants do not exist in a vacuum but in the context of communities, health systems, 
government policies and international recommendations. The latter, however, are constrained because 
of lack of empirical data on which to base clear and explicit guidelines. Common perceptions are that 
HIV-positive women rapidly deteriorate when pregnant or while breastfeeding. Although these 
perceptions likely reflect the course of women with more advanced disease, they prejudice the 
attitudes of health care workers in their daily clinical practice. In most studies investigating mother-to-
child transmission, 12–15% of HIV-positive pregnant women have CD4+ counts less than 200 x 106 
cells/L. It is not clear whether the effect of pregnancy and lactation is the same for women with 
advanced disease as for those who are still immunologically competent. This information would affect 
some or all aspects of antenatal, delivery and postnatal care. 
 Clinic and hospital staffs reflect their own views and those of their communities on what is 
the best way to feed young infants irrespective of the HIV status of women. Breastfeeding is more 
than just providing nutrition to a young infant; in many communities it also represents an important 
symbol of care. Hence a mother may feel obliged to breastfeed even when she feels unwell or when 
food is not readily available for herself. Clarification of the nutritional and health consequences of 
breastfeeding on the health of HIV-positive women would help nurses and counsellors to give the 
most appropriate counselling and support. Clarification would also provide information about whether 
breast pathology, such as mastitis, should be managed differently for HIV-positive and -negative 
women. 
 
6.       Research gaps 
 Maternal survival is of obvious importance to the mother but also for the survival of her 
children. Preliminary evidence, though scanty, suggests that an HIV-positive mother who is well 
nourished in both macro- and micronutrients is likely to have adequate health and immune function as 
 
 
determined by CD4+ cell count and viral load. Therefore, determining the best way to optimize the 
nutritional status of HIV-positive women is essential.  
 Operational research is needed on the delivery of comprehensive nutrition and health services 
to HIV-positive women to support maintenance and improvement of body composition and 
micronutrient status. Body composition assessment methods need to be investigated and validated in 
HIV-positive pregnant and lactating women. 
 
 
6.1.   Pregnancy 
 
6.1.1.  Biological research gaps  
6.1.1.1. Gestational weight gain pattern and body composition changes  
• Anthropometric cutoffs regarding risk of maternal health and disease progression  
• Practical and reliable field methods to measure body composition 
• Means to improve weight gain rate  
• For all of the above, comparison between HIV-positive women by CD4+ count,  
disease stage and viral load 
• For HIV-positive women, nutritional modifiers of maternal CD4+ count 
6.1.1.2. Appropriate micronutrient supplementation  
• Appropriate levels of micronutrient intake throughout pregnancy 
• Methods to achieve optimal intake of micronutrients 
• Dietary intake indicators of micronutrient status  
• For all of the above, comparison between HIV-positive women by CD4+ count, 
disease stage and viral load 
• For HIV-positive women, nutritional modifiers of maternal CD4+ count  
• For HIV-positive women, appropriate treatment of anaemia 
6.1.1.3. Effect of parity and birth spacing on nutritional status and disease progression 
•   Effect of HIV on lactational amenorrhea. 
  
6.1.2. Operational research gaps 
6.1.2.1. Means to deliver appropriate level of energy and micronutrients (pill versus food  
  versus fortified food product) 
• System for monitoring supply, use and need 
• Methodology to accurately assess food security and dietary diversity 
• Barriers to adequate intake 
• Efficacy, including consideration of nutritional status, quality of life, ability to work  
 and care for family, disease progression and frequency of illness, immune function 
6.1.2.2. Appropriate recommendations for frequency and amounts of locally available  
  foods to optimize maternal nutritional status 
6.1.2.3. Means to monitor BMI, change in weight and MUAC in health care facilities and  
  other community settings 
6.1.2.4. Algorithm (evidence based) to trigger nutrition intervention; may include  
  identification of at-risk individual, weight change, food insecurity). 
 
6.2. Lactation 
 
6.2.1. Biological research gaps  
6.2.1.1. Effect of breastfeeding duration and intensity 
• Micronutrient status and changes  
• Body composition changes postpartum (including a comparison of HIV-positive  
 women who are and are not breastfeeding)  
• Identification of anthropometric cutoffs regarding risk of maternal health and disease  
 progression 
• Maternal body composition changes in relation to breast milk composition (proteins,  
 immune factors, micronutrients)  
• Maternal morbidity and mortality during breastfeeding and 1–2 years afterward  
 
 
• Maternal health and breast health 
• Breast milk nutrients and immunity factors 
• For all of the above, comparison between HIV-positive women by CD4+ count,  
 disease stage and viral load  
• For HIV-positive women, effect on maternal HIV disease progression and immune 
 function  
• For HIV-positive women, effect of nutritional modifiers on maternal CD4+ counts  
 and clinical HIV disease progression 
6.2.1.2. Appropriate micronutrient supplementation  
• Appropriate levels of micronutrient intake throughout lactation 
• Methods to achieve optimal intake of micronutrients 
• Nutritional modifiers of maternal CD4+ count 
• For all of the above, comparison between HIV-positive women by CD4+ count, disease  
 stage and viral load  
• Appropriate level of iron supplementation in iron-deficient postpartum HIV-infected  
 women  
6.2.1.3. Appropriate weight loss postpartum with consideration to disease progression and  
  maternal health 
6.2.1.4. Effect of antiretroviral therapy on maternal body composition and micronutrient  
  status and breast milk nutrient composition (including proteins and micronutrients)   
  and immunity factors. 
 
6.2.2. Operational research gaps 
6.2.2.1. Means to deliver appropriate level of energy and micronutrients (pill versus food  
  versus fortified food product) 
• System for monitoring supply, use and need 
• Methodology to accurately assess food security and dietary diversity 
• Barriers to adequate intake 
• Efficacy, including consideration of nutritional status, quality of life, ability to work  
 and care for family, disease progression and frequency of illness, immune function 
6.2.2.2. Appropriate recommendations for frequency and amounts of locally available foods  
  to optimize maternal nutritional status 
6.2.2.3. Means to monitor BMI, change in weight and MUAC in health care facilities and  
  other community settings 
6.2.2.4. Development of algorithm (evidence based) to trigger nutrition intervention; may  
  include identification of at-risk individual, weight change, food insecurity). 
 
7.      Summary 
 When comparing HIV-positive and HIV-negative pregnant women, studies found little 
difference between groups in terms of weight, BMI, MUAC and triceps skinfold thickness 
measurements. Most likely, the women are at early stages of HIV infection (though ~12% had CD4+ 
counts <200 x 106 cell/L). Most studies, however, found that anthropometric measures decline with 
increasing viral load and decreasing CD4+ cell count. One study reported that HIV-positive pregnant 
women gained less weight in each trimester than HIV-negative women and generally less than the 
average weight gain reported in presumed HIV-negative women in developed countries. The rates of 
weight gain reported in HIV-positive mothers, however, are consistent with the weight gains in 
undernourished pregnant women in developing countries. A high proportion of women were found 
with low or deficient folate or vitamin A status and with anaemia, suggesting that many HIV-positive 
mothers in developing countries may not be consuming a varied diet rich in micronutrients nor 
prenatal vitamin and mineral supplements. Some evidence shows that a higher proportion of HIV-
positive pregnant women had low or deficient levels of folate, albumin and vitamin A and that these 
are associated with increased viral load and decreased CD4+ cell count.  
 The few studies comparing HIV-positive and -negative breastfeeding women found no 
difference between groups in terms of anthropometry and body composition. Though the observed 
 
 
weight loss of HIV-positive women during lactation appears to be more than that observed in HIV-
negative women, the loss of weight is similar to that seen in breastfeeding women throughout the 
world. Breastfeeding does not appear to increase maternal mortality, but increased rate of weight loss 
(>1.0 kg/month) was associated with increased risk in one study. 
 To determine appropriate nutrition interventions, estimating body composition is important 
for all HIV-positive individuals. Although advanced and sophisticated methods of measuring body 
composition are available and useful for research purposes, simple anthropometric measurements of 
height, weight, BMI, MUAC and skinfold thicknesses at four sites (triceps, biceps, subscapular and 
suprailiac) are generally useful to monitor adiposity during pregnancy and lactation. Change in weight 
is also appropriate for identifying women at nutritional risk and in need of intervention. 
Anthropometry is inexpensive, reliable if the measurer is well trained and feasible for both health 
facilities and fieldwork. Assessment of FFM is more complex and will require other types of 
measurements. 
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Table 1. Recommended weight gain during pregnancy 
 
BMI before pregnancy Total weight gain (kg) Weekly weight gain (kg) 
during 2nd and 3rd trimesters 
<19.8 12.5–18.0 0.5+ 
19.8–25.9 11.5–16.0 0.5 
26.0–29.0 7.0–11.5 0.3 
>29.0 <7.0 0.25 
 
